NCT00019110View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1995

Conditions
Anal CancerCervical CancerEsophageal CancerHead and Neck CancerPenile CancerVulvar Cancer
Interventions
BIOLOGICAL

human papillomavirus 16 E7 peptide

BIOLOGICAL

synthetic human papillomavirus 16 E6 peptide

Trial Locations (6)

20892

Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

02114-2617

Massachusetts General Hospital Cancer Center, Boston

02115

Brigham and Women's Hospital, Boston

07962-1956

Morristown Memorial Hospital, Morristown

77555-0587

University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH